Clinical Core Research Subjects
If you would like more information on our Center's Longitudinal Cohort data or are interested in potential research collaborations, please send an email to either one of our Clinical Core Co-Directors, Deborah Blacker, MD, ScD, or M. Teresa Gomez-Isla, MD, PhD.
If you would like more information on our Memory Disorders Unit (MDU) data, please send an email to either of our Clinical Core Co-Directors.
Brain Tissue Samples
If you would like more information on our Center's brain tissue samples, please send an email to our Neuropathology Core Director, Matthew P. Frosch, MD, PhD.
Cell Line, DNA & Plasma Samples
If you would like more information on our Center's biospecimen samples and associated data, please send an email to our Center Director, Bradley T. Hyman, MD, PhD.
If you would like more information on our Center's database software or hardware systems, please send an email to our Data Management & Statistics Core Co-Director, Timothy W. Clark, PhD.
If you would like more information on our Center's neuroimaging data, please send an email to our Neuroimaging Program Director, Reisa A. Sperling, MD, MMSc.
A variety of state-of-the-art molecular pathology resources from our affiliated Harvard NeuroDiscovery Advanced Tissue Resource Center (ATRC) are also available to investigators within the Harvard University and the greater-Boston research communities. Under special arrangements, such resources may also be available to the commercial sector. These include laser capture microscopy; DNA/RNA/miRNA quality/expression analysis; Luminex FlexMap 3D multiplex bead cytometry; real-time PCR and bio-reagents for neurological research. For more information on the ATRC, please visit www.neurodiscovery.harvard.edu/resources/atrc.html.
Other facilities within the greater Boston community that offers state-of-the-art instrumentation, methodologies and expertise in promoting interdisciplinary research related to neurodegenerative diseases include the following:
- BioMEMS ("BioMicroElectroMechanical") Resource Center of Harvard/MIT,
- Eagle-i Consortium, of which Harvard University is a participant.
Researchers are also encouraged to familiarize themselves with the spectrum of current AD research investments and resources (both in the U.S. and internationally) by visiting the International Alzheimer's Disease Research Portfolio (IADRP) that is developed by the NIA/NIH and the Alzheimer's Association.